BBR Partners’s Kyntra Bio KYNB Stock Holding History

BBR Partners’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-658	Closed	-$5.1K	–	246
2025 Q1	$5.1K	Hold	658	–	–	﹤0.01%	244
2024 Q4	$8.71K	Hold	658	–	–	﹤0.01%	248
2024 Q3	$6.57K	Hold	658	–	–	﹤0.01%	241
2024 Q2	$14.7K	Sell	658 -8,000	-92%	-$247K	﹤0.01%	219
2024 Q1	$509K	Buy	8,658 +8,000	+1,216%	+$345K	0.04%	140
2023 Q4	$14.6K	Buy	+658	New	+$9.93K	﹤0.01%	192
2021 Q2	–	Sell	-282	Closed	-$245K	–	205
2021 Q1	$245K	Hold	282	–	–	0.02%	182
2020 Q4	$262K	Hold	282	–	–	0.02%	157
2020 Q3	$290K	Hold	282	–	–	0.02%	144
2020 Q2	$286K	Hold	282	–	–	0.04%	133
2020 Q1	$245K	Hold	282	–	–	0.04%	122
2019 Q4	$303K	Hold	282	–	–	0.03%	147
2019 Q3	$261K	Hold	282	–	–	0.04%	111
2019 Q2	$319K	Hold	282	–	–	0.05%	95
2019 Q1	$383K	Hold	282	–	–	0.05%	100
2018 Q4	$327K	Buy	282 +20	+8%	+$22.5K	0.04%	111
2018 Q3	$398K	Hold	262	–	–	0.06%	75
2018 Q2	$410K	Hold	262	–	–	0.07%	66
2018 Q1	$303K	Hold	262	–	–	0.05%	71
2017 Q4	$311K	Buy	262 +40	+18%	+$50.2K	0.06%	56
2017 Q3	$299K	Buy	+222	New	+$234K	0.06%	46

Other funds holding KYNB

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BBR Partners's KYNB Position: Q2 2025 in Review

BBR Partners sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 658 shares — an estimated $5.1K sold.

BBR Partners first reported a position in KYNB in Q3 2017 and held it in 21 quarters. The position peaked at $509K in Q1 2024. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

BBR Partners reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
BBR Partners sold 658 Kyntra Bio shares in Q2 2025, an estimated $5.1K.
BBR Partners first reported a position in Kyntra Bio in Q3 2017 and held it in 21 quarters.
BBR Partners's Kyntra Bio position peaked at $509K in Q1 2024.
30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on BBR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.